Skip to main content
Irwin Naturals Inc. logo

Irwin Naturals Inc. — Investor Relations & Filings

Ticker · IWIN ISIN · CA46414Q1054 LEI · 9845003CF0B7JE8FAX54 CSE Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2023-08-04 Regulatory Filings
Country CA Canada
Listing CSE IWIN

About Irwin Naturals Inc.

https://irwinnaturals.com/

Irwin Naturals Inc. is a nutraceutical company focused on developing and distributing premium health supplements and vitamins. The company specializes in soft-gel based herbal formulas, prioritizing superior potency, bioavailability, and absorption. Its product portfolio includes targeted formulas for general wellness, sleep, cognitive function, detoxification, and weight management, alongside a range of CBD and THC products. A core unique selling proposition is the utilization of an all-liquid soft-gel delivery system combined with the signature BioPerine Complex, which is designed to enhance nutrient uptake. Irwin Naturals distributes its extensive line of supplements through mass-market and health food chain retailers across North America.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings
2023-08-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated July 28, 2023, announcing the launch of new cannabis tincture products by Irwin Naturals. It discusses the company's business strategy, product details, market expansion, and forward-looking statements. There are no financial statements, regulatory filings, voting results, or management changes reported. The content is promotional and informational about product launches and company strategy rather than a formal financial or regulatory report. Therefore, it fits best as a general Regulatory Filing (RNS) since it is a corporate announcement that does not fit into more specific categories like earnings release, annual report, or capital update.
2023-07-28 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Irwin Naturals' financial results for the first quarter of 2023, including revenue, net loss, EBITDA reconciliation, and operational highlights. It contains substantive financial data such as income from operations, net loss, EBITDA, and consolidated statements of financial position. The presence of detailed financial statements and analysis for a quarterly period indicates this is a comprehensive interim financial report. The document is about Q1 2023 results, which fits the definition of an Interim / Quarterly Report (IR). It is not merely an earnings release (which would be shorter and less detailed), nor is it an annual report or audit report. Therefore, the correct classification is IR with high confidence. Q1 2023
2023-06-01 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release dated 1 June 2023 from Graphene Manufacturing Group Ltd. announcing independently verified test results related to energy savings and heat transfer improvements from their product THERMAL-XR®. The content focuses on technical test results, business updates, and product applications rather than financial performance, regulatory filings, or management changes. There is no indication of financial statements, earnings data, shareholder votes, or regulatory certifications. The document is a detailed business update and product performance announcement, not a formal financial or regulatory report. Therefore, it does not fit into categories like Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or Regulatory Filings (RNS). It is also not a presentation or call transcript. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories but is a formal company disclosure to the market.
2023-06-01 English
News release - English.pdf
Annual Report Classification · 95% confidence The document is a detailed financial report from Irwin Naturals Inc. reporting year-end 2022 financial results and recent events, including financial highlights, operational updates, acquisitions, and regulatory overview. It contains comprehensive financial data such as revenue, income from operations, EBITDA reconciliation, and consolidated statements of financial position. The document also includes management commentary and forward-looking statements. The length is substantial (15,000 characters), and it is not merely an announcement of a report but contains actual financial results and analysis. Therefore, this document fits the definition of an Annual Report (10-K) or a comprehensive yearly financial report. Given the content and timing (year-end results), the best classification is Annual Report (10-K). FY 2022
2023-06-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CEO of Irwin Naturals Inc. regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2023. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The document does not contain actual financial data or the interim report itself but is a certification attesting to the accuracy and completeness of the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself. The document length is short (2996 characters), and it is clearly a certification letter, not the report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2023-05-31 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.